When a patient is experiencing symptoms of preterm labour, it is important to determine if her risk of preterm birth is real or perhaps quite low.
fFN testing detects concentration levels of the fFN protein to reliably indicate whether a woman is likely to give birth prematurely. It is used in hospitals by doctors and midwives to enable them to make a decision on the most appropriate treatment plan.
fFN testing is the only named diagnostic test recommended in the National Institute of Health and Care Excellence (NICE) clinical guidelines for preterm labour & birth.¹
A clinically proven, powerful indicator for planning and peace of mind
This link will take you to the information intended for healthcare professionals outside of the United States. Because these pages concern the international distribution activities of the QuikCheckTM fFN Test, which are not necessarily governed by US law, contents of the international pages may contain information that does not pertain to US users, including certain products that may not be cleared or approved by US Food & Drug Administration for promotion or sale in the United States. Click “Continue” to proceed, or click “Cancel” to remain in the US site.
Caution: The QuikCheck fFNTest is not sold or offered for sale in the United States or Canada.
Hologic, Inc. does not review nor control the content on non-Hologic websites. This link does not constitute an endorsement by Hologic of the content of the site you are about to visit. Hologic privacy procedures do not apply to the owners of a non-Hologic website.